GovChime
Notice ID: 885609e0a0a44507927f0fb893d641d5Award NoticeAwarded

Bupropion HCL ER

Awarded on October 6, 2022. Full description on SAM.gov.

Awarded tounder SPE2D2-23-D-0002 (source: SAM.gov award notice)• $23.3M

Overview

Posted
September 14, 2026
Notice type
Award Notice
NAICS
325412: Pharmaceutical Preparation Manufacturing
Agency
Department of WarDEFENSE LOGISTICS AGENCY

Notice details

Office
TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT
Place of performance
Hauppauge, New York, 11788
PSC
6505: DRUGS AND BIOLOGICALS
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov
Award date
Oct 6, 2022
Award amount (SAM.gov award notice)
$23.3M

Identifiers

Solicitation number
SPE2D2-23-D-0002
Notice ID
885609e0a0a44507927f0fb893d641d5
Award number (PIID)
SPE2D2-23-D-0002

Description

Modification P00010 SPE2D223D0002 is issued to invoke option year 4 for Bupropion HCL ER National Contract.

Modification P00009 SPE2D223D0002 is issued to incorporate clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026).

Modification P00008 SPE2D223D0002 is issued to invoke option year 3 for Bupropion HCL ER National Contract.

Modification P00007 SPE2D223D0002 is issued in accordance with DoD Class Deviation 2025-O0003 and Class Deviation 2025-O0004 into subject solicitation.

Modification P00006 SPE2D223D0002 is issued to invoke option year 2 for Bupropion HCL ER National Contract.

Modification P00005 SPE2D223D0002 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation.

NATIONAL CONTRACT SPE2D2-23-D-0002 BUPROPION HCL ER

Full description on SAM.gov

Award Overview

Award Number

SPE2D2-23-D-0002

Award Amount (SAM.gov award notice)

$23.3M

Award Date

Oct 6, 2022

Awardee

Awardee UEI

C1S5SQ88KY67

Awardee CAGE Code

8PNH3

Awardee Address

Hauppauge, NY 11788, UNITED STATES

Delivery Order Number

SPE2D2-23-D-0002

Original Solicitation

Notice ID: 885609e0a0a44507927f0fb893d641d5

Posted Date: Sep 14, 2026

Original Response Deadline: Not specified

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

Files (26)

  • Modification P00008 SPE2D223D0002 Option Year 3.PDF

    25 KBAdded in Solicitation version 6Posted
    Download
  • Modification P00007 SPE2D223D0002.PDF

    197 KBAdded in Solicitation version 6Posted
    Download
  • Modification P00006 SPE2D223D0002 Option Year 2.PDF

    25 KBAdded in Solicitation version 5Posted
    Download
  • Modification P00005 SPE2D223D0002.PDF

    188 KBAdded in Solicitation version 5Posted
    Download
  • Modification P00010 SPE2D223D0002 Option Year 4.PDF

    25 KBAdded in Award Notice version 7Posted
    Download
  • Signed SPE2D223D0002 P00003.pdf

    175 KBAdded in Solicitation version 5Posted
    Download
  • Modification P00009 SPE2D223D0002.PDF

    170 KBAdded in Award Notice version 7Posted
    Download
  • SF30_SPE2D223D0002P00004.PDF Signed.pdf

    18 KBAdded in Solicitation version 5Posted
    Download
  • Modification P00008 SPE2D223D0002 Option Year 3.PDF

    25 KBAdded in Award Notice version 7Posted
    Download
  • Revised Schedule of Supplies.pdf

    112 KBAdded in Solicitation version 5Posted
    Download
  • Modification P00007 SPE2D223D0002.PDF

    197 KBAdded in Award Notice version 7Posted
    Download
  • Bilaterally Signed SPE2D223D0002 P00001.pdf

    193 KBAdded in Solicitation version 5Posted
    Download
  • Modification P00006 SPE2D223D0002 Option Year 2.PDF

    25 KBAdded in Award Notice version 7Posted
    Download
  • Bilaterally Signed Bupropion HCL ER Award SPE2D2-23-D-0002.pdf

    375 KBAdded in Solicitation version 5Posted
    Download
  • Modification P00005 SPE2D223D0002.PDF

    188 KBAdded in Award Notice version 7Posted
    Download
  • SPE2D221R0105 0002.pdf

    104 KBAdded in Solicitation version 4Posted
    Download
  • SF30_SPE2D223D0002P00004.PDF Signed.pdf

    18 KBAdded in Award Notice version 6Posted
    Download
  • REVISED Page 104 Appendix B.pdf

    104 KBAdded in Solicitation version 3Posted
    Download
  • Signed SPE2D223D0002 P00003.pdf

    175 KBAdded in Award Notice version 5Posted
    Download
  • REVISED Pages 39 to 40.pdf

    126 KBAdded in Solicitation version 3Posted
    Download
  • Revised Schedule of Supplies.pdf

    112 KBAdded in Award Notice version 4Posted
    Download
  • REVISED Page 2 Schedule of Supplies.pdf

    68 KBAdded in Solicitation version 3Posted
    Download
  • Bilaterally Signed SPE2D223D0002 P00001.pdf

    193 KBAdded in Award Notice version 3Posted
    Download
  • SPE2D221R0105 0001.pdf

    136 KBAdded in Solicitation version 3Posted
    Download
  • Bilaterally Signed Bupropion HCL ER Award SPE2D2-23-D-0002.pdf

    375 KBAdded in Award Notice version 2Posted
    Download
  • Bupropion HCL ER National Contracts Solicitation SPE2D2-21-R-0105.pdf

    1.6 MBAdded in Solicitation version 2Posted
    Download

Lifecycle

  1. 1
    Version 1Solicitation

    Bupropion HCL ER

    Notice 833b3fd5d9cc431d97fab24e0626576f on SAM.gov

  2. 2
    Version 2Award Notice

    Type changed from Solicitation to Award Notice

    Bupropion HCL ER

    Notice 3ed0dc5a0b124e338340e3303b4723c8 on SAM.gov

  3. 3
    Version 3Award Notice

    Bupropion HCL ER

    Notice 75b57b4539d64675a7fa8f9f1d1e9536 on SAM.gov

  4. 4
    Version 4Award Notice

    Bupropion HCL ER

    Notice 90ac1c4312ef48a2a43bb03a51991edc on SAM.gov

  5. 5
    Version 5Award Notice

    Bupropion HCL ER

    Notice 89be6e8793454feebad5a6b3746e8cb2 on SAM.gov

  6. 6
    Version 6Award Notice

    Bupropion HCL ER

    Notice 407c49e6ed694cad8b3b370d64a83ef4 on SAM.gov

  7. 7
    Version 7Award NoticeCurrent

    Bupropion HCL ER

    Notice 885609e0a0a44507927f0fb893d641d5 on SAM.gov

Similar Opportunities

Additional Details

Solicitation Number

SPE2D2-23-D-0002

Archive Date

Oct 6, 2028

Office Address

PHILADELPHIA, PA, 19111